CorMedix Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $311.7 | $43.5 | — | $0.1 | $0.2 |
| Operating income | $150.1 | -$22.4 | -$49.0 | -$30.6 | -$29.4 |
| Net income | $163.1 | -$17.9 | -$46.3 | -$29.7 | -$28.2 |
| Cash Flow Statement | |||||
| Free cash flow | $172.8 | -$50.7 | -$38.7 | -$24.6 | -$22.6 |
Shares outstanding 77.9M · Free float 94.8%
Annual filing data through FY ended December 31, 2025; float as of September 10, 2026.